GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹349 Cr | ₹256 Cr | ₹230 Cr | ₹132 Cr | ₹68 Cr |
What is the latest Total Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹349 Cr |
| Mar2025 | ₹256 Cr |
| Mar2024 | ₹230 Cr |
| Mar2023 | ₹132 Cr |
| Mar2022 | ₹68 Cr |
How is Total Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹349 Cr | 36.28 | |
| Mar2025 | ₹256 Cr | 11.36 | |
| Mar2024 | ₹230 Cr | 73.82 | |
| Mar2023 | ₹132 Cr | 94.30 | |
| Mar2022 | ₹68 Cr | - | |
Compare Total Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹215.5 Cr | -2.2% | 0.2% | -40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -2.2% |
0.2% |
-40.2% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses